Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
38 (15%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT LATANOPROST/TIMOLOL | 5MG 50MCG | SOLUTION | Actual shortage | 2021-08-27 | 2022-08-18 | 144701 |
| TEVA-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2021-09-16 | 2024-03-18 | 145783 |
| ACT REPAGLINIDE | 0.5MG | TABLET | Actual shortage | 2021-11-18 | 2021-11-18 | 149591 |
| ACT REPAGLINIDE | 1MG | TABLET | Actual shortage | 2021-11-18 | 2021-11-18 | 149596 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Actual shortage | 2021-11-18 | 2022-08-18 | 149602 |
| ACT REPAGLINIDE | 2MG | TABLET | Actual shortage | 2021-11-18 | 2021-11-18 | 149606 |
| TEVA-ACYCLOVIR | 800MG | TABLET | Actual shortage | 2021-11-25 | 2021-11-25 | 149928 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Actual shortage | 2021-12-17 | 2023-11-03 | 151465 |
| TEVA-TOPOTECAN | 4MG | POWDER FOR SOLUTION | Actual shortage | 2022-05-19 | 2022-05-19 | 160980 |
| TEVA-ZOLMITRIPTAN OD | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Actual shortage | 2022-05-19 | 2022-12-01 | 161012 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 10MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Actual shortage | 2022-08-18 | 2024-05-16 | 166969 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 20MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Actual shortage | 2022-08-18 | 2024-05-16 | 166972 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 30MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Actual shortage | 2022-08-18 | 2024-05-16 | 166975 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Actual shortage | 2022-08-18 | 2022-08-19 | 167162 |
| TEVA-PRAZOSIN | 1MG | TABLET | Actual shortage | 2022-11-14 | 2023-12-21 | 174592 |
| TEVA-PRAZOSIN | 2MG | TABLET | Actual shortage | 2022-12-01 | 2023-12-21 | 176803 |
| TEVA-PRAZOSIN | 5MG | TABLET | Actual shortage | 2022-12-01 | 2023-12-21 | 176806 |
| TEVA-ZOPICLONE | 5MG | TABLET | Actual shortage | 2023-02-02 | 2024-02-01 | 183386 |
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Actual shortage | 2023-02-09 | 2024-04-25 | 184216 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-04-27 | 2024-05-09 | 190785 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |